Change in MYCN-driven cell state opens therapeutic window in high-risk neuroblastoma
- OPACC
- Apr 10, 2024
- 1 min read
A switch between cell states within MYCN-amplified neuroblastoma promotes KDM4, inhibition of which shows promising anticancer potential.
Comments